Chemopreventive efficacies of aspirin and sulindac against lung tumorigenesis in A/J mice.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Carcinogenesis

• Publication date

  1997-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/CARCIN/18.5.1001PMID 9163687
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sulindac: A Review of its Pharmacological Properties and Therapeutic Efficacy in Rheumatic Diseases

  2012cited by this paper
• Tobacco-specific nitrosamines in Canadian cigarettes

  2005cited by this paper
• Effects of nonsteroidal antiinflammatory drugs on oxidative pathways in A/J mice.

  1995cited by this paper
• Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent.

  1995cited by this paper
• Activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human lung microsomes by cytochromes P450, lipoxygenase, and hydroperoxides.

  1995cited by this paper
• Aspirin Use and Lung, Colon, and Breast Cancer Incidence in a Prospective Study

  1994cited by this paper
• Nonsteroidal antiinflammatory agents in chemoprevention of colorectal cancer at what cost?

  1994cited by this paper
• Tobacco-specific nitrosamines.

  1994cited by this paper
• Characterization of a human cell line expressing high levels of cDNA-derived CYP2D6.

  1993cited by this paper
• The A/J mouse lung as a model for developing new chemointervention strategies.

  1993cited by this paper
• Aspirin use and risk of fatal cancer.

  1993cited by this paper
• Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats.

  1993cited by this paper
• Inhibitory effects of nonsteroidal anti-inflammatory drugs (NSAIDs) on the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in mouse lung explants.

  1993cited by this paper
• Effects of pregnancy and ethanol treatment on the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by hamster liver and lung microsomes.

  1992cited by this paper
• Aspirin and the potential role of prostaglandins in colon cancer.

  1992cited by this paper
• Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human lung and liver microsomes and cytochromes P-450 expressed in hepatoma cells.

  1992cited by this paper
• Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes.

  1992cited by this paper
• Effects of NSAIDs on NNK-induced pulmonary and gastric tumorigenesis in A/J mice.

  1992cited by this paper
• Effects of sulindac and oltipraz on the tumorigenicity of 4-(methylnitrosamino)1-(3-pyridyl)-1-butanone in A/J mouse lung.

  1992cited by this paper
• Kinetics and enzyme involvement in the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in microsomes of rat lung and nasal mucosa.

  1992cited by this paper
• Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by inducible and constitutive cytochrome P450 enzymes in rats.

  1992cited by this paper
• The pharmacokinetics of aspirin in rats and the effect of buffer

  1991cited by this paper
• DNA-expressed human cytochrome P450s: a new age of molecular toxicology and human risk assessment.

  1991cited by this paper
• Effects of various prostaglandin synthesis inhibitors on pancreatic carcinogenesis in hamsters after initiation with N-nitrosobis(2-oxopropyl)amine.

  1990cited by this paper
• Investigations on the origin of tobacco-specific nitrosamines in mainstream smoke of cigarettes.

  1990cited by this paper
• The relevance of tobacco-specific nitrosamines to human cancer.

  1989cited by this paper
• Inhibitory effects of non-steroidal anti-inflammatory drugs, piroxicam and indomethacin on 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in male ACI/N rats.

  1989cited by this paper
• Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke.

  1988cited by this paper
• Modulation of methylcholanthrene-induced carcinogenesis in the uterine cervix of mouse by indomethacin.

  1988cited by this paper
• Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug, during different stages of rat colon tumor development.

  1987cited by this paper
• Inhibition by aspirin of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide initiation and sodium saccharin promotion of urinary bladder carcinogenesis in male F344 rats.

  1986cited by this paper
• Sulindac metabolism: The importance of an intact colon

  1985cited by this paper
• Antitumoral activity of indomethacin on experimental esophageal tumors.

  1984cited by this paper
• Sulindac for polyposis of the colon

  1983cited by this paper
• Correction

  1983cited by this paper
• On the formation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone during smoking.

  1983cited by this paper
• Effect of the prostaglandin synthetase inhibitor indomethacin on 7,12-dimethylbenz(a)anthracene-induced mammary tumorigenesis in rats fed different levels of fat.

  1983cited by this paper
• Sulindac: therapeutic implications of the prodrug/pharmacophore equilibrium.

  1981cited by this paper
• Pharmacokinetics of salicylates in elderly.

  1979cited by this paper
• The pharmacokinetics of Norpace.

  1975cited by this paper
• Lung tumors in mice: application to carcinogenesis bioassay.

  1975cited by this paper
• [What is pharmacokinetics?].

  1967cited by this paper
• The Pharmacological Basis of Therapeutics

  1966cited by this paper
• The Pharmacological Basis of Therapeutics

  1941cited by this paper

• Proteome derangement in malignant epithelial cells and its stroma following exposure to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone

  2022cites this paper
• Suppressing the activation of protein kinase A as a DNA damage-independent mechanistic lead for dihydromethysticin (DHM) prophylaxis of NNK-induced lung carcinogenesis.

  2022cites this paper
• NNAL, a major metabolite of tobacco-specific carcinogen NNK, promotes lung cancer progression through deactivating LKB1 in an isomer-dependent manner

  2021cites this paper
• Aspirin Inhibition of Group VI Phospholipase A2 Induces Synthetic Lethality in AAM Pathway Down-Regulated Gingivobuccal Squamous Carcinoma

  2021cites this paper
• Anti-platelet treatments in cancer: Basic and clinical research.

  2018cites this paper
• Nitric oxide-donating aspirin (NO-Aspirin) suppresses lung tumorigenesis in vitro and in vivo and these effects are associated with modulation of the EGFR signaling pathway

  2018cites this paper
• Low-dose aspirin and survival from lung cancer : a population

  2017cites this paper
• Platelet-targeted pharmacologic treatments as anti-cancer therapy

  2017cites this paper
• A Way Forward for Cancer Chemoprevention: Think Local

  2016cites this paper
• Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.

  2016cites this paper
• Low-dose aspirin and survival from lung cancer: a population-based cohort study

  2015cites this paper
• Inflammation and Lung Cancer: Prevention

  2015cites this paper
• The role of inflammation in lung cancer.

  2014cites this paper
• Combination of cancer immunotherapy with clinically available drugs that can block immunosuppressive cells

  2014cites this paper
• Efficacy of acetylsalicylic acid (aspirin) in skin B16-F0 melanoma tumor-bearing C57BL/6 mice

  2014cites this paper
• Rol de la inflamación sistémica en la patología generada por tumores murinos

  2014cites this paper
• Lung cancer chemoprevention: difficulties, promise and potential agents?

  2013cites this paper
• A Novel Sulindac Derivative Inhibits Lung Adenocarcinoma Cell Growth through Suppression of Akt/mTOR Signaling and Induction of Autophagy

  2013cites this paper
• cancer for dose-dependent effect Evaluation of cyclooxygenase-2 inhibition in an orthotopic murine model of lung

  2013cites this paper
• Randomized phase II trial of sulindac for lung cancer chemoprevention.

  2013cites this paper
• Polycyclic Aromatic Hydrocarbon-Induced Signaling Events Relevant to Inflammation and Tumorigenesis in Lung Cells Are Dependent on Molecular Structure

  2013cites this paper
• Chemoprevention of Lung Cancer: Prospects and Disappointments in Human Clinical Trials

  2013cites this paper
• Chemical Therapeutics A Novel Sulindac Derivative Inhibits Lung Adenocarcinoma Cell Growth through Suppression of Akt / mTORSignaling and Induction of Autophagy

  2013cites this paper
• Chemoprevention with acetylsalicylic acid, vitamin D and calcium reduces risk of carcinogen-induced lung tumors.

  2013cites this paper
• Aerosol Administration of Phospho-Sulindac Inhibits Lung Tumorigenesis

  2013cites this paper
• Phospho-Sulindac (OXT-328) Inhibits the Growth of Human Lung Cancer Xenografts in Mice: Enhanced Efficacy and Mitochondria Targeting by its Formulation in Solid Lipid Nanoparticles

  2012cites this paper
• Cyclooxygenase-2 expression is not a marker of poor survival in lung cancer.

  2012cites this paper
• Preclinical Predictors of Anticancer Drug Efficacy: Critical Assessment with Emphasis on Whether Nanomolar Potency Should Be Required of Candidate Agents

  2012cites this paper
• Selective cyclooxygenase-2 inhibitor prevents cisplatin-induced tumorigenesis in A/J mice.

  2012cites this paper
• Carcinogenic Effects of Cigarette Smoke on the Respiratory Tract

  2010cites this paper
• The effect of prostaglandin synthase inhibitor, aspirin on the rat intestinal membrane structure and function.

  2010cites this paper
• Effect of etoricoxib, a cyclooxygenase-2 selective inhibitor on aberrant crypt formation and apoptosis in 1,2 dimethyl hydrazine induced colon carcinogenesis in rat model.

  2010cites this paper
• Regulation of cytokine-induced prostanoid and nitric oxide synthesis by extracellular signal–regulated kinase 1/2 in lung epithelial cells

  2010cites this paper
• Chemoprevention of lung carcinogenesis in addicted smokers and ex-smokers

  2009cites this paper
• Targeted delivery of anti-inflammatory agents to tumors.

  2009cites this paper
• Review Paper: The Role of Inflammation in Mouse Pulmonary Neoplasia

  2009cites this paper
• Lung tumor promotion by curcumin.

  2009cites this paper
• Chapter 5 Molecular Mechanisms of 4‐(Methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanone‐Induced Lung Carcinogenesis

  2009cites this paper
• Experimental Animal Models for Studying Lung Cancer

  2009cites this paper
• Chemopreventive effects of gefitinib on nonsmoking-related lung tumorigenesis in activating epidermal growth factor receptor transgenic mice.

  2009cites this paper
• Aspirin intake suppresses MMC-induced genotoxicity in mice.

  2008cites this paper
• NSAIDs revisited: putative molecular basis of their interactions with peroxisome proliferator-activated gamma receptor (PPARgamma).

  2008cites this paper
• Anti-tumor effect of non-steroidal anti-inflammatory drugs on human ovarian cancers

  2008cites this paper
• Histological Alterations in Male A/J Mice Following Nose-Only Exposure to Tobacco Smoke

  2007influential citation
• Specific components of prostanoid-signaling pathways are present in non-small cell lung cancer cells.

  2007cites this paper
• Effect of aspirin on DNA damage induced by MMC in Drosophila.

  2007cites this paper
• Sulindac and its metabolites induce carcinogen metabolizing enzymes in human colon cancer cells

  2007cites this paper
• Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer.

  2007cites this paper
• Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.

  2007cites this paper
• Inflammation and lung carcinogenesis: applying findings in prevention and treatment

  2007cites this paper
• Factors Associated with Human Small Aggressive Non–Small Cell Lung Cancer

  2007cites this paper
• Inhibition of human Neuroblastoma in SCID mice by low-dose of selective Cox-2 inhibitor Nimesulide

  2006cites this paper
• 9-cis-Retinoic acid inhibition of lung carcinogenesis in the A/J mouse model is accompanied by increased expression of RAR-beta but no change in cyclooxygenase-2.

  2006cites this paper
• Laboratory Models of Lung Cancer

  2006cites this paper
• Use of nonsteroidal antiinflammatory drugs and non-Hodgkin lymphoma: a population-based case-control study.

  2006cites this paper
• Peroxisome Proliferator‐Activated Receptors: Potential Therapeutic Targets in Lung Disease?

  2006cites this paper
• Prognostic significance of cyclooxygenase 2 expression in 259 cases of non-small cell lung cancer.

  2005cites this paper
• Immunosuppressive networks in the tumour environment and their therapeutic relevance

  2005cites this paper
• A study of the apoptotic pathways affected by lipoxygenase enzyme inhibitors

  2005cites this paper
• Silica induces human cyclooxygenase-2 gene expression through the NF-kappaB signaling pathway.

  2005cites this paper
• Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma

  2005cites this paper
• Cytokines differentially regulate the synthesis of prostanoid and nitric oxide mediators in tumorigenic versus non-tumorigenic mouse lung epithelial cell lines.

  2005cites this paper
• Evaluation of cyclooxygenase-2 inhibition in an orthotopic murine model of lung cancer for dose-dependent effect.

  2005cites this paper
• Sulindac regulates the aryl hydrocarbon receptor-mediated expression of Phase 1 metabolic enzymes in vivo and in vitro.

  2005cites this paper
• Lung Krüppel-like factor (LKLF) is a transcriptional activator of the cytosolic phospholipase A2 alpha promoter.

  2005cites this paper
• Sulindac induces apoptosis and protects against colon carcinoma in mice.

  2005cites this paper
• Chemoprevention and modulation of molecular biomarkers in mouse lung tumors.

  2005cites this paper
• Mechanisms Involved in A/J Mouse Lung Tumorigenesis Induced by Inhalation of an Environmental Tobacco Smoke Surrogate

  2005cites this paper
• Inhibition of Human Glioma Cell Growth by a PHS-2 Inhibitor, NS398, and a Prostaglandin E Receptor Subtype EP1-selective Antagonist, SC51089

  2004cites this paper
• Susceptibility to neoplastic and non-neoplastic pulmonary diseases in mice: genetic similarities.

  2004cites this paper
• Cyclooxygenase as a Target in Lung Cancer

  2004cites this paper
• Cyclooxygenase-2 Inhibitor Nimesulide Suppresses Telomerase Activity by Blocking Akt/PKB Activation in Gastric Cancer Cell Line

  2004cites this paper
• Celecoxib: a novel treatment for lung cancer

  2004cites this paper
• Genetic Selection For High Acute Inflammatory Response Confers Resistance To Lung Carcinogenesis In The Mouse

  2004cites this paper
• Crosstalk of oncogenic and prostanoid signaling pathways

  2004cites this paper
• ROLE OF INFLAMMATION IN MOUSE LUNG TUMORIGENESIS: A Review

  2004cites this paper
• Cell cycle arrest and modulation of HO-1 expression induced by acetyl salicylic acid in hepatocarcinogenesis.

  2004cites this paper
• Celecoxib: a potent cyclooxygenase-2 inhibitor in cancer prevention.

  2004cites this paper
• NSAIDs and chemoprevention.

  2004cites this paper
• Cyclooxygenase-2 in lung carcinogenesis and chemoprevention: Roger S. Mitchell lecture.

  2004cites this paper
• Induction and Modulation of Lung Tumors: Genomic and Transcriptional Alterations in Cigarette Smoke-exposed Mice

  2004cites this paper
• Prostacyclin and Lung Cancer Chemoprevention

  2004cites this paper
• Role of cyclooxygenase-2 inhibitors in combination with radiation therapy in lung cancer.

  2003cites this paper
• The Role of Cyclooxygenase-2 in the Prevention and Therapy of Lung Cancer

  2003cites this paper
• Aspirin use and lung cancer in men

  2003cites this paper
• Epidermal growth factor receptors and cyclooxygenase-2 in the pathogenesis of non-small cell lung cancer: potential targets for chemoprevention and systemic therapy.

  2003cites this paper
• The potential contributions of chronic inflammation to lung carcinogenesis.

  2003cites this paper
• Lung cancer and cyclooxygenase-2.

  2003cites this paper
• Combining cytotoxic chemotherapy with cyclooxygenase-2 inhibition.

  2003cites this paper
• Chemoprevention of Cancer by NSAIDs and Selective COX-2 Blockade

  2003cites this paper
• Chemoprevention of Breast Cancer by Nonsteroidal Anti-Inflammatory Drugs and Selective COX-2 Blockade in Animals

  2003cites this paper
• Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues.

  2002cites this paper
• Quantitative trait locus mapping of susceptibilities to butylated hydroxytoluene-induced lung tumor promotion and pulmonary inflammation in CXB mice.

  2002cites this paper
• COX-2 inhibitors in cancer treatment and prevention, a recent development.

  2002cites this paper
• Expression of cyclooxygenase‐1 and cyclooxygenase‐2 in bronchial epithelium and nonsmall cell lung carcinoma

  2002cites this paper
• Peroxisome proliferator-activated receptor-gamma is a target of nonsteroidal anti-inflammatory drugs mediating cyclooxygenase-independent inhibition of lung cancer cell growth.

  2002cites this paper
• Aspirin potently inhibits oxidative DNA strand breaks: implications for cancer chemoprevention.

  2002cites this paper
• Animal models for studying lung cancer and evaluating novel intervention strategies.

  2002cites this paper
• Regular aspirin use and lung cancer risk

  2002cites this paper
• Mechanisms of smoking-related lung and pancreatic adenocarcinoma development

  2002cites this paper